ASX Release ASX:TTX CEO REMARKS 2026 AGM 12 November 2026 In accordance with Listing Rule 3.13.3, please see the remarks to be presented at the Tetratherix Limited (ASX:TTX) (Tetratherix) 2026 AGM by Will Knox our CEO. A year ago we listed on the ASX with a clear thesis and FY26 was the year we put...
CEO Address to Shareholders
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The CEO discusses the company's progress in developing its Tetramatrix innovation and achieving revenue generation for the first time. Key highlights include FDA submissions for bone regeneration products and partnerships with major companies in the medical field.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Tetratherix
- Stronger economics, local ecosystem expansion
- Application for quotation of securities - TTX
- Details of Auditor Appointment/Resignation
- Quarterly Activities/Appendix 4C Cash Flow Report
- TegenEOS Biologic Pathway
Later from Tetratherix
All Tetratherix news releasesFollow Tetratherix into a list and get an email when it puts out news.
Follow Tetratherix